Imaging has emerged as one of the key tools used by biomedical investigators to further our understanding of human biology in health and disease. While the scale and scope of imaging research have exploded, informatics tools to support this research have not kept pace. The overarching aim of this proposal is to develop a comprehensive open source imaging informatics platform built to the highest engineering standards and using the most advanced software technologies available. This platform - XNAT 2.0 - will build on the existing XNAT platform, which is widely used by research institutions across the world and is a component of the National Institutes of Health-sponsored research informatics backbone that includes the Biomedical Informatics Research Network (BIRN) and Cancer Biomedical Informatics Grid (caBIG). The XNAT 2.0 platform will be implemented as service-oriented architecture (SOA), and a suite of services will be built on this architecture to support the core requirements of the imaging research enterprise. Software interfaces will also be designed and implemented in XNAT 2.0 to support the development of third party XNAT tools and components and to encourage developers of image processing and analysis tools to interoperate with XNAT. Finally, methods will be designed and implemented to deploy XNAT services on massively scalable computing systems. The resulting platform will improve the quality and scale of imaging research and will greatly facilitate multi-site collaboration and data sharing. Most importantly, it will provide researchers and their institutions with the necessary tools to maximize the potential of imaging to improve health and our understanding of human biology.

Public Health Relevance

In vivo imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB009352-04
Application #
8322815
Study Section
Special Emphasis Panel (ZRG1-SBIB-Q (90))
Program Officer
Pai, Vinay Manjunath
Project Start
2009-09-01
Project End
2013-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
4
Fiscal Year
2012
Total Cost
$325,443
Indirect Cost
$111,336
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Su, Yi; Flores, Shaney; Hornbeck, Russ C et al. (2018) Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin 19:406-416
Javaherian, Kavon; Newman, Brianne M; Weng, Hua et al. (2018) Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease. Alzheimer Dis Assoc Disord :
Lee, Seonjoo; Zimmerman, Molly E; Narkhede, Atul et al. (2018) White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. PLoS One 13:e0195838
Chhatwal, Jasmeer P; Schultz, Aaron P; Johnson, Keith A et al. (2018) Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain 141:1486-1500
Franzmeier, Nicolai; Düzel, Emrah; Jessen, Frank et al. (2018) Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain 141:1186-1200
Wildburger, Norelle C; Gyngard, Frank; Guillermier, Christelle et al. (2018) Amyloid-? Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity. Front Neurol 9:169
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98
Gordon, Brian A; Blazey, Tyler M; Su, Yi et al. (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol 17:241-250
Lim, Yen Ying; Hassenstab, Jason; Goate, Alison et al. (2018) Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease. Ann Neurol 84:424-435
Mishra, Shruti; Blazey, Tyler M; Holtzman, David M et al. (2018) Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ?4 genotype. Brain 141:1828-1839

Showing the most recent 10 out of 39 publications